Literature DB >> 9738926

The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.

P Nyberg1, B Dahlbäck, P García de Frutos.   

Abstract

Activated protein C (APC) regulates blood coagulation by degrading factor Va (FVa) and factor VIIIa (FVIIIa). Protein S is a cofactor to APC in the FVa degradation, whereas FVIIIa degradation is potentiated by the synergistic APC-cofactor activity of protein S and factor V (FV). To elucidate the importance of the sex-hormone-binding globulin (SHBG)-like region in protein S for expression of anticoagulant activity, a recombinant protein S/Gas6 chimera was constructed. It comprised the amino-terminal half of protein S and the SHBG-like region of Gas6, a structurally similar protein having no known anticoagulant properties. The protein S/Gas6 chimera expressed 40-50%, APC-cofactor activity in plasma as compared to wild-type protein S. In the degradation of FVa by APC, the protein S/Gas6 chimera was only slightly less efficient than wild-type protein S. In contrast, the protein S/Gas6 chimera expressed no FV-dependent APC-cofactor activity in a FVIIIa-degradation system. This demonstrates the SHBG-like region to be important for expression of APC-cofactor activity of protein S and suggests that the SHBG-like region of protein S interacts with FV during the APC-mediated inactivation of FVIIIa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738926     DOI: 10.1016/s0014-5793(98)00877-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

2.  Superior mesenteric venous thrombosis associated with a familial missense mutation (Pro626Leu) in the SHBG-like domain of the protein S molecule.

Authors:  Miyuki Kato; Shinsuke Iida; Mikinori Sato; Yoshihito Hayami; Ichiro Hanamura; Kazuhisa Miura; Masato Ito; Shinsuke Harada; Hirokazu Komatsu; Atsushi Wakita; Tadao Manabe; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.

Authors:  Marianne L Shahsuvaryan
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

4.  Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.

Authors:  Laura Llacuna; Cristina Bárcena; Lola Bellido-Martín; Laura Fernández; Milica Stefanovic; Montserrat Marí; Carmen García-Ruiz; José C Fernández-Checa; Pablo García de Frutos; Albert Morales
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.

Authors:  Nour Al Kafri; Josefin Ahnström; Adrienn Teraz-Orosz; Ludovic Chaput; Natesh Singh; Bruno O Villoutreix; Sassan Hafizi
Journal:  Biochem Biophys Rep       Date:  2022-04-28

6.  Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach.

Authors:  Romain A Studer; Fred R Opperdoes; Gerry A F Nicolaes; André B Mulder; René Mulder
Journal:  Open Biol       Date:  2014-10       Impact factor: 6.411

7.  Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.

Authors:  Salvatore Santamaria; Natalia Reglińska-Matveyev; Magdalena Gierula; Rodney M Camire; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

8.  The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Authors:  Magdalena Gierula; Isabelle I Salles-Crawley; Salvatore Santamaria; Adrienn Teraz-Orosz; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  J Thromb Haemost       Date:  2019-08-09       Impact factor: 5.824

9.  Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lfs* 23) and c.6521G > T (p.C2174F).

Authors:  Baolai Hua; Xiaobo Yan; Bin He; Lianjun Shen; Man-Chiu Poon
Journal:  Clin Case Rep       Date:  2022-08-24

10.  TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Authors:  Natalia Reglińska-Matveyev; Helena M Andersson; Suely M Rezende; Björn Dahlbäck; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.